Di-tert-butyl pyridine-2,6-diyldicarbamate

Catalog No. :
ACFIDZ624
CAS No. :
852617-12-0
Molecular Formula :
C15H23N3O4
Molecular Weight :
309.37

IUPAC Name:di-tert-butyl pyridine-2,6-diyldicarbamate

Di-tert-butyl pyridine-2,6-diyldicarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$75.00Login to see priceInquiryInquiry
1g98%$199.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDi-tert-butyl pyridine-2,6-diyldicarbamate
IUPAC Namedi-tert-butyl pyridine-2,6-diyldicarbamate
MDL No.MFCD16621689
Molecular FormulaC15H23N3O4
Molecular Weight309.37
SMILESO=C(NC1=CC=CC(NC(OC(C)(C)C)=O)=N1)OC(C)(C)C
InChI KeyQVPCQNKHMFGPLW-UHFFFAOYSA-N
SynonymN,N'-di-tert-butoxycarbonyl-2,6-diaminopyridine;2,6-DI-(BOC-AMINO)PYRIDINE;di-tert-butyl pyridine-2,6-diyldicarbamate;Carbamic acid, N,N'-2,6-pyridinediylbis-, C,C'-bis(1,1-dimethylethyl) ester
CAS No.852617-12-0
PubChem CID86051323

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFIDZ624 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRNAT270 route compound structure diagram
    ACRNAT270322690-31-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFIDZ624 route product structure diagram
    ACFIDZ624852617-12-0
Inquiry

2. ACFIDZ624 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRNAT270 route compound structure diagram
    ACRNAT270322690-31-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFIDZ624 route product structure diagram
    ACFIDZ624852617-12-0
Inquiry

Comments (0)